Antibiogram Matrix Factorization for Sparse Resistance Prediction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for predicting antibiotic resistance are limited by sparse data sets and the need for direct testing, which can be time-consuming and delay treatment decisions, especially when data from various sources are aggregated and sparse, particularly for antibiotic resistance data.
Innovation Solution
A matrix factorization approach is used to analyze antibiogram data, transforming it into a reconstruction matrix that predicts antibiotic resistance and susceptibility by linking microorganisms to antibiotic drugs, even in the absence of direct observations, through latent factor analysis and machine learning techniques.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional antibiogram testing methods are used to determine antibiotic susceptibility, then accurate resistance prediction is achieved, but time consumption increases and treatment decisions are delayed
Solution Approach 1:
The patent applies preliminary action by using matrix factorization to pre-process and analyze antibiogram data from multiple sources before clinical testing. The system pre-computes resistance patterns and creates a reconstructed matrix that can quickly predict susceptibility, eliminating the need to wait for time-consuming culture results while maintaining accuracy through预先 prepared data structures
Solution Approach 2:
The patent creates a reconstructed matrix that copies and synthesizes information from multiple source antibiograms. This virtual copy contains aggregated resistance patterns that can be queried instantly without performing actual culture tests, providing rapid prediction while preserving the accuracy of comprehensive testing through data replication and synthesis
2Quantity of substance
If data from multiple sources are aggregated to improve prediction coverage, then data completeness improves, but data sparsity increases
Solution Approach 1:
The patent merges multiple source antibiograms into a single reconstructed matrix by combining data from different hospitals and laboratories. This consolidation fills in sparse regions by aggregating observations across sources, transforming individual sparse matrices into a denser composite structure that improves overall data coverage while maintaining the quantitative relationships needed for accurate prediction
Solution Approach 2:
The patent adds a new dimension to the data structure by creating a reconstructed matrix that synthesizes information across multiple source dimensions. This additional dimensional layer allows the system to access resistance patterns from aggregate data without being constrained by the sparsity of any single source, enabling comprehensive coverage while preserving detailed information
3Productivity
If machine learning approaches are used to predict antibiotic resistance, then scalability improves, but predictive power decreases due to sparse data
Solution Approach 1:
The patent introduces a reconstructed matrix as an intermediary structure between raw antibiogram data and machine learning prediction. This intermediate representation aggregates and densifies the data, providing a richer feature set for ML algorithms while maintaining scalability. The reconstructed matrix serves as a mediator that preserves predictive information while enabling efficient large-scale processing
Data Source
AI summary
A method is described that utilizes non-negative matrix factorization to predict susceptibility of a microorganism to an antimicrobial drug. A sparse adjacency matrix is constructed from existing ground truth datasets that include antibiogram data and other data associated with microorganisms. The rows of the adjacency matrix correspond to biosamples, and the columns correspond to instances of metadata and drugs associated with one or more of the biosamples. The elements of the adjacency matrix are assigned non-zero numerical values or zero depending on whether a known association exists. The adjacency matrix is then factored using a selected number of latent factors, thereby producing a reconstruction matrix approximating the adjacency matrix. The values of the reconstruction matrix are used to predict antimicrobial susceptibility of a biosample ID to a drug when antibiogram data are lacking.